Concord Medical

Concord Medical operates a network of radiotherapy and diagnostic imaging centers across China, focused on providing comprehensive oncology healthcare services. The company serves cancer patients directly through its own medical institutions and also supplies third-party medical facilities with advanced medical equipment, software, and related services. As of December 31, 2012, Concord Medical's network included 136 centers located in 76 hospitals, primarily within high-ranking 3A hospitals, spanning 53 cities across 24 provinces. The company has made significant investments in the healthcare sector, including acquiring a majority stake in Chang’an Hospital and a minority interest in The University of Texas MD Anderson Cancer Center Proton Therapy Center. Its revenue mainly stems from its hospital operations and the provision of medical equipment and services to other medical institutions.